An article from Reuters Health titled, "Vitamin E, anti-inflammatories show benefit in Alzheimer's disease," points out the results of clinical data suggesting that treating Alzheimer's patients with vitamin E and anti-inflammatory drugs, along with a cholinesterase inhibitor, can slow Alzheimer's induced decline.
The data was gathered from 540 patients who were receiving standard treatment with a cholinesterase inhibitor such as Aricept, Exelon or Razadyne. According to the article, a...
There’s been quite a ruckus started by Ron Reagan’s memoir of his father, President Ronald Reagan. The book, “My Father at 100,”... Read more »
It wasn't all that long ago when most people, including many doctors, felt that there really wasn't much point in diagnosing Alzheimer's... Read more »
Sleep…ahhh, sweet, sweet sleep… In my last blog, I wrote about the benefits of sleep. Since then, I have managed a couple of... Read more »
So many times during my teaching career—and especially during the last years—I would stand inside my classroom, nervously looking at ... Read more »
I am taking an eclectic approach with this week’s blog. In other words, there is no real theme…just thoughts. First, I must... Read more »
French researchers say they have found a way to diagnose Alzheimer's disease by using automated magnetic resonance imaging (MRI). The MRI is able to... Read more »
Source: ADAM Encyclopedia
www.nia.nih.gov/alzheimers -- Alzheimer's Disease Education and Referral Center (U.S. National Institute on Aging)www.alz.org -- Alzheimer's... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
